A detailed history of Cgc Financial Services, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Cgc Financial Services, LLC holds 1,131 shares of ABBV stock, worth $200,130. This represents 0.09% of its overall portfolio holdings.

Number of Shares
1,131
Previous 922 22.67%
Holding current value
$200,130
Previous $158 Million 41.24%
% of portfolio
0.09%
Previous 0.07%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$163.84 - $199.33 $34,242 - $41,659
209 Added 22.67%
1,131 $223 Million
Q1 2024

Apr 22, 2024

BUY
$159.82 - $182.1 $10,867 - $12,382
68 Added 7.96%
922 $168 Million
Q4 2023

Jan 12, 2024

BUY
$137.6 - $154.97 $30,960 - $34,868
225 Added 35.77%
854 $132 Million
Q2 2023

Sep 12, 2023

BUY
$132.51 - $164.9 $83,348 - $103,722
629 New
629 $84.7 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $313B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Cgc Financial Services, LLC Portfolio

Follow Cgc Financial Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cgc Financial Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cgc Financial Services, LLC with notifications on news.